2/1/2010

LipoScience has filed an application with the FDA seeking clearance for Vantera, a device that would enable research laboratories to conduct on-site testing of blood samples for risks of heart diseases. CEO Rick Brajer said he is hopeful the company can secure FDA clearance later this year.

Related Summaries